E
Ultragenyx Pharmaceutical Inc. RARE
$39.34 $0.090.23%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue 560.23M 522.75M 481.30M 442.59M 434.25M
Total Other Revenue -- -- -- -- --
Total Revenue 560.23M 522.75M 481.30M 442.59M 434.25M
Cost of Revenue 1.11B 1.06B 1.05B 1.04B 1.02B
Gross Profit -554.35M -537.58M -568.99M -599.78M -590.06M
SG&A Expenses 321.61M 315.95M 310.51M 311.31M 309.80M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 1.10B 1.06B 1.03B 1.02B 1.00B
Operating Income -535.97M -535.74M -548.85M -580.45M -569.21M
Income Before Tax -567.59M -561.07M -586.86M -615.22M -608.46M
Income Tax Expenses 1.60M -2.09M -1.74M -1.87M -1.83M
Earnings from Continuing Operations -569.18 -558.99 -585.12 -613.35 -606.64
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -569.18M -558.99M -585.12M -613.35M -606.64M
EBIT -535.97M -535.74M -548.85M -580.45M -569.21M
EBITDA -500.43M -501.06M -515.74M -550.84M -543.20M
EPS Basic -6.34 -6.46 -7.29 -8.03 -8.33
Normalized Basic EPS -3.94 -4.07 -4.57 -5.06 -5.22
EPS Diluted -6.34 -6.47 -7.30 -8.03 -8.33
Normalized Diluted EPS -3.94 -4.07 -4.57 -5.06 -5.22
Average Basic Shares Outstanding 362.04M 347.48M 323.65M 307.97M 294.05M
Average Diluted Shares Outstanding 362.04M 347.48M 323.65M 307.97M 294.05M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings